Global Ranitidine (Zantac) Market Outlook 2022

Global Ranitidine (Zantac) Market Outlook 2022

Table of Contents
1 Ranitidine (Zantac) Market Overview
1.1 Product Overview and Scope of Ranitidine (Zantac)
1.2 Ranitidine (Zantac) Segment by Type
1.2.1 Global Ranitidine (Zantac) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ranitidine Capsule
1.2.3 Ranitidine Oral Tablet
1.2.4 Ranitidine Injectable Solution
1.2.5 Ranitidine Oral Syrup
1.3 Ranitidine (Zantac) Segment by Application
1.3.1 Global Ranitidine (Zantac) Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Ranitidine (Zantac) Market Size Estimates and Forecasts
1.4.1 Global Ranitidine (Zantac) Revenue 2016-2027
1.4.2 Global Ranitidine (Zantac) Sales 2016-2027
1.4.3 Ranitidine (Zantac) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Ranitidine (Zantac) Market Competition by Manufacturers
2.1 Global Ranitidine (Zantac) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Ranitidine (Zantac) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Ranitidine (Zantac) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Ranitidine (Zantac) Manufacturing Sites, Area Served, Product Type
2.5 Ranitidine (Zantac) Market Competitive Situation and Trends
2.5.1 Ranitidine (Zantac) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ranitidine (Zantac) Players Market Share by Revenue
2.5.3 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ranitidine (Zantac) Retrospective Market Scenario by Region
3.1 Global Ranitidine (Zantac) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Ranitidine (Zantac) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Ranitidine (Zantac) Market Facts & Figures by Country
3.3.1 North America Ranitidine (Zantac) Sales by Country
3.3.2 North America Ranitidine (Zantac) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ranitidine (Zantac) Market Facts & Figures by Country
3.4.1 Europe Ranitidine (Zantac) Sales by Country
3.4.2 Europe Ranitidine (Zantac) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ranitidine (Zantac) Market Facts & Figures by Region
3.5.1 Asia Pacific Ranitidine (Zantac) Sales by Region
3.5.2 Asia Pacific Ranitidine (Zantac) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ranitidine (Zantac) Market Facts & Figures by Country
3.6.1 Latin America Ranitidine (Zantac) Sales by Country
3.6.2 Latin America Ranitidine (Zantac) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ranitidine (Zantac) Market Facts & Figures by Country
3.7.1 Middle East and Africa Ranitidine (Zantac) Sales by Country
3.7.2 Middle East and Africa Ranitidine (Zantac) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ranitidine (Zantac) Historic Market Analysis by Type
4.1 Global Ranitidine (Zantac) Sales Market Share by Type (2016-2021)
4.2 Global Ranitidine (Zantac) Revenue Market Share by Type (2016-2021)
4.3 Global Ranitidine (Zantac) Price by Type (2016-2021)
5 Global Ranitidine (Zantac) Historic Market Analysis by Application
5.1 Global Ranitidine (Zantac) Sales Market Share by Application (2016-2021)
5.2 Global Ranitidine (Zantac) Revenue Market Share by Application (2016-2021)
5.3 Global Ranitidine (Zantac) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Ranitidine (Zantac) Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Ranitidine (Zantac) Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Hi-Tech Pharmacal Co.
6.3.1 Hi-Tech Pharmacal Co. Corporation Information
6.3.2 Hi-Tech Pharmacal Co. Description and Business Overview
6.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product Portfolio
6.3.5 Hi-Tech Pharmacal Co. Recent Developments/Updates
6.4 Sun Pharma
6.4.1 Sun Pharma Corporation Information
6.4.2 Sun Pharma Description and Business Overview
6.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sun Pharma Ranitidine (Zantac) Product Portfolio
6.4.5 Sun Pharma Recent Developments/Updates
6.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
6.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
6.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
6.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product Portfolio
6.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Developments/Updates
6.6 Dr. Reddy's Laboratories Inc.
6.6.1 Dr. Reddy's Laboratories Inc. Corporation Information
6.6.2 Dr. Reddy's Laboratories Inc. Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Product Portfolio
6.6.5 Dr. Reddy's Laboratories Inc. Recent Developments/Updates
6.7 Sandoz Inc. (part of Novartis AG)
6.6.1 Sandoz Inc. (part of Novartis AG) Corporation Information
6.6.2 Sandoz Inc. (part of Novartis AG) Description and Business Overview
6.6.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product Portfolio
6.7.5 Sandoz Inc. (part of Novartis AG) Recent Developments/Updates
6.8 Strides (and Strides Arcolab international)
6.8.1 Strides (and Strides Arcolab international) Corporation Information
6.8.2 Strides (and Strides Arcolab international) Description and Business Overview
6.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Product Portfolio
6.8.5 Strides (and Strides Arcolab international) Recent Developments/Updates
6.9 Geri-Care Pharmaceuticals
6.9.1 Geri-Care Pharmaceuticals Corporation Information
6.9.2 Geri-Care Pharmaceuticals Description and Business Overview
6.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Product Portfolio
6.9.5 Geri-Care Pharmaceuticals Recent Developments/Updates
6.10 PAI Holdings, LLC
6.10.1 PAI Holdings, LLC Corporation Information
6.10.2 PAI Holdings, LLC Description and Business Overview
6.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 PAI Holdings, LLC Ranitidine (Zantac) Product Portfolio
6.10.5 PAI Holdings, LLC Recent Developments/Updates
6.11 Teva Pharmaceuticals
6.11.1 Teva Pharmaceuticals Corporation Information
6.11.2 Teva Pharmaceuticals Ranitidine (Zantac) Description and Business Overview
6.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Teva Pharmaceuticals Ranitidine (Zantac) Product Portfolio
6.11.5 Teva Pharmaceuticals Recent Developments/Updates
6.12 Granules Pharmaceuticals Inc.
6.12.1 Granules Pharmaceuticals Inc. Corporation Information
6.12.2 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Description and Business Overview
6.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product Portfolio
6.12.5 Granules Pharmaceuticals Inc. Recent Developments/Updates
6.13 Glenmark Pharmaceuticals (and Glenmark Generics)
6.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
6.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Description and Business Overview
6.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product Portfolio
6.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Developments/Updates
6.14 Apotex Inc. (and Apotex Corporation)
6.14.1 Apotex Inc. (and Apotex Corporation) Corporation Information
6.14.2 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Description and Business Overview
6.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product Portfolio
6.14.5 Apotex Inc. (and Apotex Corporation) Recent Developments/Updates
6.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
6.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
6.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Description and Business Overview
6.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product Portfolio
6.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Developments/Updates
7 Ranitidine (Zantac) Manufacturing Cost Analysis
7.1 Ranitidine (Zantac) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ranitidine (Zantac)
7.4 Ranitidine (Zantac) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ranitidine (Zantac) Distributors List
8.3 Ranitidine (Zantac) Customers
9 Ranitidine (Zantac) Market Dynamics
9.1 Ranitidine (Zantac) Industry Trends
9.2 Ranitidine (Zantac) Growth Drivers
9.3 Ranitidine (Zantac) Market Challenges
9.4 Ranitidine (Zantac) Market Restraints
10 Global Market Forecast
10.1 Ranitidine (Zantac) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ranitidine (Zantac) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Ranitidine (Zantac) by Type (2022-2027)
10.2 Ranitidine (Zantac) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ranitidine (Zantac) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Ranitidine (Zantac) by Application (2022-2027)
10.3 Ranitidine (Zantac) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ranitidine (Zantac) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Ranitidine (Zantac) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Ranitidine (Zantac) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Ranitidine (Zantac) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Ranitidine (Zantac) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Ranitidine (Zantac) Covered in This Study
Table 5. Global Ranitidine (Zantac) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Ranitidine (Zantac) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Ranitidine (Zantac) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Ranitidine (Zantac) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Ranitidine (Zantac) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Ranitidine (Zantac) Manufacturing Sites and Area Served
Table 11. Manufacturers Ranitidine (Zantac) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ranitidine (Zantac) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranitidine (Zantac) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ranitidine (Zantac) Sales by Region (2016-2021) & (K Units)
Table 16. Global Ranitidine (Zantac) Sales Market Share by Region (2016-2021)
Table 17. Global Ranitidine (Zantac) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 19. North America Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 20. North America Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 22. Europe Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 24. Europe Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Ranitidine (Zantac) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Ranitidine (Zantac) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Ranitidine (Zantac) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Ranitidine (Zantac) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 32. Latin America Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Ranitidine (Zantac) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Ranitidine (Zantac) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Ranitidine (Zantac) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Ranitidine (Zantac) Revenue Market Share by Country (2016-2021)
Table 38. Global Ranitidine (Zantac) Sales (K Units) by Type (2016-2021)
Table 39. Global Ranitidine (Zantac) Sales Market Share by Type (2016-2021)
Table 40. Global Ranitidine (Zantac) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Ranitidine (Zantac) Revenue Share by Type (2016-2021)
Table 42. Global Ranitidine (Zantac) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Ranitidine (Zantac) Sales (K Units) by Application (2016-2021)
Table 44. Global Ranitidine (Zantac) Sales Market Share by Application (2016-2021)
Table 45. Global Ranitidine (Zantac) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Ranitidine (Zantac) Revenue Share by Application (2016-2021)
Table 47. Global Ranitidine (Zantac) Price (US$/Unit) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Ranitidine (Zantac) Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. GlaxoSmithKline Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline Ranitidine (Zantac) Product
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Hi-Tech Pharmacal Co. Corporation Information
Table 59. Hi-Tech Pharmacal Co. Description and Business Overview
Table 60. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product
Table 62. Hi-Tech Pharmacal Co. Recent Developments/Updates
Table 63. Sun Pharma Corporation Information
Table 64. Sun Pharma Description and Business Overview
Table 65. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sun Pharma Ranitidine (Zantac) Product
Table 67. Sun Pharma Recent Developments/Updates
Table 68. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
Table 69. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
Table 70. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product
Table 72. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Developments/Updates
Table 73. Dr. Reddy's Laboratories Inc. Corporation Information
Table 74. Dr. Reddy's Laboratories Inc. Description and Business Overview
Table 75. Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Dr. Reddy's Laboratories Inc. Ranitidine (Zantac) Product
Table 77. Dr. Reddy's Laboratories Inc. Recent Developments/Updates
Table 78. Sandoz Inc. (part of Novartis AG) Corporation Information
Table 79. Sandoz Inc. (part of Novartis AG) Description and Business Overview
Table 80. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product
Table 82. Sandoz Inc. (part of Novartis AG) Recent Developments/Updates
Table 83. Strides (and Strides Arcolab international) Corporation Information
Table 84. Strides (and Strides Arcolab international) Description and Business Overview
Table 85. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product
Table 87. Strides (and Strides Arcolab international) Recent Developments/Updates
Table 88. Geri-Care Pharmaceuticals Corporation Information
Table 89. Geri-Care Pharmaceuticals Description and Business Overview
Table 90. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product
Table 92. Geri-Care Pharmaceuticals Recent Developments/Updates
Table 93. PAI Holdings, LLC Corporation Information
Table 94. PAI Holdings, LLC Description and Business Overview
Table 95. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. PAI Holdings, LLC Ranitidine (Zantac) Product
Table 97. PAI Holdings, LLC Recent Developments/Updates
Table 98. Teva Pharmaceuticals Corporation Information
Table 99. Teva Pharmaceuticals Description and Business Overview
Table 100. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Teva Pharmaceuticals Ranitidine (Zantac) Product
Table 102. Teva Pharmaceuticals Recent Developments/Updates
Table 103. Granules Pharmaceuticals Inc. Corporation Information
Table 104. Granules Pharmaceuticals Inc. Description and Business Overview
Table 105. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product
Table 107. Granules Pharmaceuticals Inc. Recent Developments/Updates
Table 108. Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
Table 109. Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
Table 110. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product
Table 112. Glenmark Pharmaceuticals (and Glenmark Generics) Recent Developments/Updates
Table 113. Apotex Inc. (and Apotex Corporation) Corporation Information
Table 114. Apotex Inc. (and Apotex Corporation) Description and Business Overview
Table 115. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product
Table 117. Apotex Inc. (and Apotex Corporation) Recent Developments/Updates
Table 118. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
Table 119. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
Table 120. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product
Table 122. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Ranitidine (Zantac) Distributors List
Table 126. Ranitidine (Zantac) Customers List
Table 127. Ranitidine (Zantac) Market Trends
Table 128. Ranitidine (Zantac) Growth Drivers
Table 129. Ranitidine (Zantac) Market Challenges
Table 130. Ranitidine (Zantac) Market Restraints
Table 131. Global Ranitidine (Zantac) Sales Forecast by Type (2022-2027) & (K Units)
Table 132. Global Ranitidine (Zantac) Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Ranitidine (Zantac) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Ranitidine (Zantac) Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Ranitidine (Zantac) Sales Forecast by Application (2022-2027) & (K Units)
Table 136. Global Ranitidine (Zantac) Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Ranitidine (Zantac) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Ranitidine (Zantac) Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Ranitidine (Zantac) Sales Forecast by Region (2022-2027) & (K Units)
Table 140. Global Ranitidine (Zantac) Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Ranitidine (Zantac) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Ranitidine (Zantac) Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ranitidine (Zantac)
Figure 2. Global Ranitidine (Zantac) Market Share by Type in 2020 & 2027
Figure 3. Ranitidine Capsule Product Picture
Figure 4. Ranitidine Oral Tablet Product Picture
Figure 5. Ranitidine Injectable Solution Product Picture
Figure 6. Ranitidine Oral Syrup Product Picture
Figure 7. Global Ranitidine (Zantac) Market Share by Application in 2020 & 2027
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Ranitidine (Zantac) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ranitidine (Zantac) Market Size 2016-2027 (US$ Million)
Figure 13. Global Ranitidine (Zantac) Sales 2016-2027 (K Units)
Figure 14. Global Ranitidine (Zantac) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Ranitidine (Zantac) Sales Share by Manufacturers in 2020
Figure 16. Global Ranitidine (Zantac) Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Ranitidine (Zantac) Players: Market Share by Revenue in 2020
Figure 18. Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Ranitidine (Zantac) Sales Market Share by Region (2016-2021)
Figure 20. Global Ranitidine (Zantac) Sales Market Share by Region in 2020
Figure 21. Global Ranitidine (Zantac) Revenue Market Share by Region (2016-2021)
Figure 22. Global Ranitidine (Zantac) Revenue Market Share by Region in 2020
Figure 23. U.S. Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Ranitidine (Zantac) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Ranitidine (Zantac) by Type (2016-2021)
Figure 48. Sales Market Share of Ranitidine (Zantac) by Application (2016-2021)
Figure 49. Sales Market Share of Ranitidine (Zantac) by Application in 2020
Figure 50. Revenue Share of Ranitidine (Zantac) by Application (2016-2021)
Figure 51. Revenue Share of Ranitidine (Zantac) by Application in 2020
Figure 52. Manufacturing Cost Structure of Ranitidine (Zantac)
Figure 53. Manufacturing Process Analysis of Ranitidine (Zantac)
Figure 54. Ranitidine (Zantac) Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs